Post-COVID-19 cavitary lung lesion due to Aspergillus flavus and Enterobacter cloacae in a patient suffering from COVID-19 pneumonia – a case report

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has manifested as a multifaceted paradigm but has primarily affected the respiratory system. Though a rare sequela after-COVID-19, we present a case of cavitary lung lesion in an adult patient, which manifested with common symptoms such as fever, cough and dyspnoea during the post-COVID-19 recovery period. Aspergillus flavus and Enterobacter cloacae were found to be the main causative organisms. Fungal and bacterial coinfection may be thought of in similar situations and appropriate treatment may be given to prevent further morbidity and mortality.

Pulmonary Cavitation as a Complication of COVID-19: Case Series and a Brief Review of the Literature

“…The subsequent development of invasive pulmonary aspergillosis underscores the importance of vigilance in observing severe COVID-19 pneumonia patients for potential opportunistic infections, particularly with prolonged corticosteroid therapy. Similarly, Rajpal et al's study [33] reported a rare sequela of pulmonary cavitation following COVID-19 recovery in an adult patient, with cavitary lung lesions attributed to Aspergillus flavus and Enterobacter cloacae. This highlights the possibility of fungal and bacterial coinfections in post-COVID-19 recovery, emphasizing the need for prompt recognition and appropriate treatment to prevent further morbidity and mortality.…”